Feedback / Questions
RDX-002 - Response Pharma
https://www.businesswire.com/news/home/20250813869741/en/Response-Pharmaceuticals-Announces-Positive-Top-Line-Results-From-Phase-2-Study-of-RDX-002-in-Post-GLP-1-Management
Aug 13, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next